HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Evaluation of the effects of reduced glutathione in subjects with acquired and congenital changes in heme biosynthesis].

Abstract
In order to evaluate the possible therapeutical effects of reduced glutathione in subjects affected by acquired or congenital heme biosynthesis alterations, two groups of subjects have been considered: the first, of 5 subjects with abnormal lead absorption, the second of 10 patients suffering from porphyria cutanea tarda (PCT). The drug was administered i.v. at the dosage of 600-1200 mg for a variable period of 3-5 days in the first group, for 7-10 days in the patients with PCT. In the lead-exposed subjects an increase in the activity of ALA-dehydratases enzyme was observed, with a decrease in the urinary excretion of delta-aminolevulinic acid, and a decrease in the percentage of urinary coproporphyrins as well. In the patients with PCT, after the therapy, a relevant reduction of urinary excretion of porphyrins, prevalently uro- and heptaporphyrins, was noticed. The results of this preliminary study suggest that glutathione can exert an effect of "normalization" on heme biosynthesis when altered in acquired and/or congenital conditions.
AuthorsA Ferioli, A De Vincentiis, P Buizza, G Pasolini, C Leali, G De Panfilis, L Alessio
JournalMinerva medica (Minerva Med) Vol. 83 Issue 5 Pg. 269-75 (May 1992) ISSN: 0026-4806 [Print] Italy
Vernacular TitleValutazione degli effetti del glutatione ridotto in soggetti con alterazioni acquisite e congenite della biosintesi dell'eme.
PMID1589131 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Coproporphyrins
  • Porphyrins
  • Uroporphyrins
  • Heme
  • Aminolevulinic Acid
  • Glutathione
Topics
  • Aminolevulinic Acid (urine)
  • Coproporphyrins (urine)
  • Glutathione (administration & dosage, therapeutic use)
  • Heme (biosynthesis)
  • Humans
  • Lead Poisoning (drug therapy, metabolism)
  • Porphyrias (drug therapy, metabolism)
  • Porphyrins (urine)
  • Skin Diseases (drug therapy, metabolism)
  • Time Factors
  • Uroporphyrins (urine)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: